The Court of Appeals for the Federal Circuit recently addressed the issue of “analogous prior art,” a patent law doctrine fundamental to the legal determination of whether a patent is invalid as obvious over the prior art....more
11/6/2023
/ Analogous Art ,
Appeals ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Mylan Pharmaceuticals ,
Patent Invalidity ,
Patent Trial and Appeal Board ,
Patentability Search ,
Patents ,
Prior Art ,
Sanofi-Aventis